Portola Pharma (PTLA) Stock Price & Overview

NASDAQ:PTLA

18.03
+0.04 (+0.22%)
At close: Jul 1, 2020
18.02
-0.01 (-0.06%)
After Hours: 7/1/2020, 8:13:07 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

The current stock price of PTLA is 18.03 null. Today PTLA is up by 0.22%. In the past month the price increased by 0.56%. In the past year, price decreased by -31.65%.

PTLA Key Statistics

52-Week Range5.31 - 31.73
Current PTLA stock price positioned within its 52-week range.
1-Month Range17.89 - 18.07
Current PTLA stock price positioned within its 1-month range.
Market Cap
1.415B
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-3.72
Dividend Yield
N/A

PTLA Stock Performance

Today
+0.22%
1 Week
+0.45%
1 Month
+0.56%
3 Months
+179.54%
Longer-term
6 Months -24.81%
1 Year -31.65%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

PTLA Stock Chart

Portola Pharma / PTLA Daily stock chart

PTLA Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to PTLA. When comparing the yearly performance of all stocks, PTLA is one of the better performing stocks in the market, outperforming 94.88% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
PTLA Full Technical Analysis Report

PTLA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to PTLA. PTLA has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
PTLA Full Fundamental Analysis Report

PTLA Earnings

Next Earnings DateN/A
Last Earnings DateN/A
PTLA Earnings History

PTLA Forecast & Estimates


Analysts
Analysts88
Price TargetN/A
EPS Next Y39.41%
Revenue Next YearN/A
PTLA Forecast & Estimates

PTLA Financial Highlights

Over the last trailing twelve months PTLA reported a non-GAAP Earnings per Share(EPS) of -3.72. The EPS increased by 21.68% compared to the year before.


Income Statements
Revenue(TTM)120.86M
Net Income(TTM)-281.28M
Industry RankSector Rank
PM (TTM) -232.73%
ROA -54.8%
ROE N/A
Debt/Equity 4.77
Chartmill High Growth Momentum
EPS Q2Q%13.73%
Sales Q2Q%19.04%
EPS 1Y (TTM)21.68%
Revenue 1Y (TTM)117.16%
PTLA financials

PTLA Ownership

Ownership
Inst Owners98.68%
Shares78.48M
Float44.71M
Ins Owners5.95%
Short Float %N/A
Short RatioN/A
PTLA Ownership

About PTLA

Company Profile

Portola Pharmaceuticals, Inc. is a biopharmaceutical company .It focuses on the development and commercialization of therapeutics for thrombosis, other hematologic disorders and inflammation. Portola Pharmaceuticals, Inc. is headquartered in South San Francisco, California.

Company Info

Portola Pharma

270 EAST GRAND AVENUE

SOUTH SAN FRANCISCO CA 94080

CEO: Scott Garland

Phone: 650-246-7000

Portola Pharma / PTLA FAQ

What does PTLA do?

Portola Pharmaceuticals, Inc. is a biopharmaceutical company .It focuses on the development and commercialization of therapeutics for thrombosis, other hematologic disorders and inflammation. Portola Pharmaceuticals, Inc. is headquartered in South San Francisco, California.


What is the current price of PTLA stock?

The current stock price of PTLA is 18.03 null. The price increased by 0.22% in the last trading session.


What is the dividend status of Portola Pharma?

PTLA does not pay a dividend.


What is the ChartMill technical and fundamental rating of PTLA stock?

PTLA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the market capitalization of PTLA stock?

Portola Pharma (PTLA) has a market capitalization of 1.42B null. This makes PTLA a Small Cap stock.